CDEK
← All organizations
Pierre Fabre

Pierre Fabre

For profitContributed to NMEWebsite ↗

Also known as: Centre de Recherche sur La Peau | Institut de Recherche Pierre Fabre | Laboratoires Pierre Fabre | Orfagen | ORFAGEN LABORATORIES (France) | PIERRE FABRE | Pierre Fabre BIOMETRIE | PIERRE FABRE DERMA | Pierre Fabre Dermatology | Pierre Fabre Dermo Cosmetique | Pierre Fabre Ibérica, S.A. | Pierre Fabre Laboratories | Pierre Fabre Medicament | Pierre Fabre Medicament (co-developer) | Pierre Fabre Pharma GmbH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 1, 2002

First marketed drug

Dec 23, 1994

First NDA

Dec 23, 1994

Last known activity

Aug 31, 2025

Timeline

1960s

  1. Jan 1, 1962

    Pierre Fabre— Founded

1990s

  1. Dec 23, 1994

    vinorelbine— NDA Secondary Org

  2. Dec 23, 1994

    vinorelbine— NDA Organization

2000s

  1. Jan 1, 2002

    Genesis Laboratories— Acquired

  2. Jan 1, 2006

    Darrow Laboratories— Acquired

2010s

  1. Mar 14, 2014

    propranolol— Marketing Organization

  2. May 24, 2017

    Igenica Biotherapeutics, Inc.— Acquired

Drugs by trial phase (101 distinct, 111 trials)

Indications

Approved for

Studied for

Marketed drugs (3)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Paris, FR Jan 1, 1962
First NDA
Dec 23, 1994
Last known activity
Aug 31, 2025

Designations held

  • Priority review